Earnings results for NeuroPace (NASDAQ:NPCE)
Neuropace, Inc. is expected* to report earnings on 06/03/2021 before market open. The report will be for the fiscal Quarter ending Mar 2021. According to Zacks Investment Research, based on 2 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0.25.
Analyst Opinion on NeuroPace (NASDAQ:NPCE)
4 Wall Street analysts have issued ratings and price targets for NeuroPace in the last 12 months. Their average twelve-month price target is $25.75, predicting that the stock has a possible upside of 14.50%. The high price target for NPCE is $27.00 and the low price target for NPCE is $25.00. There are currently 4 buy ratings for the stock, resulting in a consensus rating of “Buy.”
NeuroPace has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings. According to analysts’ consensus price target of $25.75, NeuroPace has a forecasted upside of 14.5% from its current price of $22.49. NeuroPace has only been the subject of 4 research reports in the past 90 days.
Dividend Strength: NeuroPace (NASDAQ:NPCE)
NeuroPace does not currently pay a dividend. NeuroPace does not have a long track record of dividend growth.
Insiders buying/selling: NeuroPace (NASDAQ:NPCE)
In the past three months, NeuroPace insiders have bought more of their company’s stock than they have sold. Specifically, they have bought $4,884,984.00 in company stock and sold $0.00 in company stock.
Earnings and Valuation of NeuroPace (NASDAQ:NPCE
Earnings for NeuroPace are expected to grow in the coming year, from ($1.08) to ($1.04) per share.
More latest stories: here